Grade 4 IDH-mutant astrocytomas are discriminated from their LGIMA counterparts based on the presence of the homozygous deletion of CDKN2A/2B, the existence of microvascular proliferation or necrosis, or any combination of these three features. The gene discussed is IDH2; the disease is astrocytoma (excluding glioblastoma).